Key result
Obesity-driven inflammation disrupts visceral adipose Tregs, which normally comprise ~70% of resident CD4+ T cells.
Why the study?
Visceral adipose tissue regulatory T cells control inflammation and alleviate metabolic disease, but this population is disrupted in obesity. Understanding the microenvironmental and metabolic factors governing their accumulation and maintenance is crucial for identifying mechanisms of obesity-associated metabolic disease and developing novel therapies.
Answers are grounded in this paper and cite their sources.
Understanding how microenvironmental cytokines, antigens, hormones, and metabolic pathways integrate to regulate visceral adipose tissue Tregs may guide combination therapies to restore Treg homeostasis and alleviate obesity-associated metabolic disease.
Since their discovery over a decade ago, much has been learned regarding the importance and function of visceral adipose tissue (VAT)-resident regulatory T cells (Tregs). VAT Tregs play a critical role in controlling VAT inflammation and alleviating metabolic disease. However, this population is disrupted in obesity which exacerbates VAT inflammation and metabolic abnormalities. Therefore, understanding the factors governing the accumulation and maintenance of VAT Tregs, both at steady state and under disease conditions, is crucial for identifying the mechanisms underlying obesity-associated metabolic disease and developing novel therapies. Expansion and maintenance of the VAT Treg compartment is strongly influenced by factors in the local tissue microenvironment, including cytokines, T-cell receptor ligands, hormones, and various metabolites. This mini-review will primarily focus on recent advances in our understandings regarding the regulation of mouse epididymal VAT (eVAT) Tregs, which are the most thoroughly characterized VAT Treg population, by tissue microenvironmental factors and cellular metabolic processes. We will also briefly discuss the limited knowledge available regarding the regulation of mouse ovarian VAT (oVAT) Tregs and human omental VAT Tregs, highlight some lingering questions, and provide a prospective view on where the field is heading.
No takes yet. Share an insight, caveat, or question.
Elkins et al. (2022) conducted a review in Obesity-associated visceral adipose tissue inflammation and metabolic disease. Cytokine, T-cell receptor, hormonal, and metabolic regulation of visceral adipose tissue Tregs was evaluated on Accumulation, maintenance, and function of visceral adipose tissue regulatory T cells (VAT Tregs). Visceral adipose tissue Tregs make up 60% to 80% of CD4+ T cells in lean male mouse epididymal fat by 20-30 weeks of age, but are disrupted in obesity by inflammatory cytokines such as IFNα, TNFα, and IFNγ.
Synapse has enriched 10 related papers. Consider them for comparative context: